Biomedtracker

Report Library

Datamonitor Pharma's Patient Centricity

February 29, 2016

Datamonitor's independent research and analysis provides extensive coverage of major disease areas, companies and strategic issues, giving you the perspective to identify opportunities and threats arising from shifting market dynamics and the insights to respond with faster, more effective decision-making. This strategy report focuses on Datamonitor Pharma's Patient Centricity including driver and resistors of patient centricity, changing organizations and cultures, and selected case studies along the value chain.

Case Studies

UCB: reorganizing around patients.
Sanofi: diffusing patient centric innovation (SNY).
LEO Pharma: leading the pack in patient centricity.
Actelion: new approaches to patient-relevant trial measures (ALIOF).
AstraZeneca: engaging patients in research (AZN).
Novo Nordisk: a patient-centric heritage (NVO).
Shire: spreading patient centricity beyond rare diseases (SHPG).

For more information on Datamonitor strategy reports, please email BioMedTracker or call BioMedTracker Client Services at (858) 200-2357.

For our disclosures, please read the BioMedTracker Research Standards.

Disease Group Covered:

Allergy
Autoimmune/immunology
Cardiovascular
Dermatology
Endocrine
ENT/Dental
Gastroenterology (Non Inflammatory Bowel Disease)
Hematology
Infectious Disease
Metabolic
Neurology
Not Specified
Obstetrics/Gynecology
Oncology
Ophthalmology
Orthopedics
Psychiatry
Renal
Respiratory
Rheumatology (Non Autoimmune)
Urology

Additional Resources: